Clinical trial
Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With…
NCT00068549 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00068549 |
|---|---|
| Title | Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer |
| Official title | A Phase I Study of Whole Pelvic Radiation Therapy With Concomitant Cisplatin and Gemcitabine Chemotherapy in Patients With Cervical Carcinoma (Stages I-IV) Limited to the Pelvis |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Gemcitabine Hydrochloride, Cisplatin, Radiation Therapy, Internal Radiation Therapy |
| Enrollment | 13 |
| Start date | Oct 1, 2003 |
| Primary completion | Jan 1, 2008 |
| First posted | Sep 11, 2003 |
| Last update posted | Dec 25, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: